Vaccine Development & Commercialization
As the result of the COVID-19 pandemic, the industry learned a great deal about ways in which vaccine development and market introduction can be streamlined, particularly in an emergency situation.
However, many of these learnings can be applied to advance the efficiency of effectiveness of vaccine development in general. BioTechLogic’s team of experts has deep expertise and experience working on the front lines of vaccine development.
Complete Vaccine Development Support Services
BioTechLogic has extensive experience with vaccine development and commercialization, from preclinical to market. As you are considering the fastest path to market, we are here to help.
Vaccine Development & Production
BioTechLogic has extensive experience supporting the development and commercialization of vaccines.
How BioTechLogic Can Help
-
- Product characterization
- Analytical method development
- Critical Quality Attributes understanding
-
- Potency assays
- Production strategy selection and decision making
- Comparability studies
-
- Stability studies
- Transportation strategies
- Raw material/excipient, and other materials compliance
- Regulatory filing support
Vaccine CMC Services
CMC Strategy
Quality Assurance
Analytical Services
Regulatory Consulting & Submissions Support
Process Development & Validation
Contract Services & Tech Transfer Support
Supply Chain Management
Inspection Readiness
Project Management
Years
Consultants
Clients
projects
Vaccine Resources
Biopharmaceutical Developers Tackle COVID-19 Pandemic-Inflicted Challenges
Tonia Becker, Life Sciences Editor, Macon Raine, talks with BioTechLogic's Dr. Mike Berry. Knowing that BioTechLogic’s team of biopharmaceutical consultants is working with many companies in the industry to help speed the path to market, I was interested in learning...
Top 10 U.S. Biopharma Clusters
Bruce Booth, D.Phil., a partner at Atlas Venture, astutely observed earlier this year that two key resources fueling the growth of biopharma were until recently somewhat geographically spread among the 10 or so regions of the nation where the industry began to arise a...
Response to the Publication of USP ‹1207›: Package Integrity Evaluation-Sterile Products
The BioPhorum Operation Group’s (BPOG’s) Container Closure Integrity Testing (CCIT) workstream would like to congratulate the United States Pharmacopeia’s committee for its latest revision to USP chapter <1207> Package Integrity Evaluation: Sterile Products....
